They observed that the expression levels of GAD1 and SLC1A2 were lower in the DLPFC of subjects with MDD as compared to controls and, that GAD1 mRNA levels were significantly associated with SLC1A2 mRNA expression levels in the same area in the group of MDD patients. The gene discussed is SLC1A2; the disease is major depressive disorder.